Skip to main content
Article

HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity – The HBM4EU survey

Liese GillesVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium. Electronic address: [email protected]Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), Mol, BelgiumLoïc RambaudSanté Publique France, French Public Health Agency (ANSP), Saint-Maurice, FranceNina VogelGerman Environment Agency (UBA), Berlin, GermanyArgelia CastañoNational Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, SpainMarta EstebanNational Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, SpainLaura Rodríguez MartínVITO Health, Flemish Institute for Technological Research (VITO), Mol, BelgiumGudrun KoppenVITO Health, Flemish Institute for Technological Research (VITO), Mol, BelgiumSylvie RémyVITO Health, Flemish Institute for Technological Research (VITO), Mol, BelgiumMartine VrijheidBarcelona Institute for Global Health (ISGlobal), Barcelona, SpainParisa MontazeriBarcelona Institute for Global Health (ISGlobal), Barcelona, SpainLaura Ellen BirksBarcelona Institute for Global Health (ISGlobal), Barcelona, SpainOvnair SepaiPublic Health England, Chilton, United KingdomLorraine StewartPublic Health England, Chilton, United KingdomUlrike FiddickeGerman Environment Agency (UBA), Berlin, GermanyIlse LootsDepartment of Sociology (CRESC) and IMDO, University of Antwerp, Antwerp, BelgiumLisbeth E. KnudsenDepartment of Public Health, University of Copenhagen, DenmarkMarike Kolossa‐GehringGerman Environment Agency (UBA), Berlin, GermanyGreet SchoetersVITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; University of Southern Denmark, Institute of Public Health, Department of Environmental Medicine, Odense, Denmark
2021en
ABI

Abstract

As part of the Human Biomonitoring for Europe (HBM4EU) initiative a human biomonitoring (HBM) survey is conducted in 21 countries. This survey builds on existing HBM capacity in Europe by aligning national or regional HBM studies. The survey targets 3 age groups (i) children aged 6-11 years, (ii) teenagers aged 12-19 years and (iii) young adults aged 20-39 years and includes a total of 9493 participants (3151 children, 2953 teenagers and 3389 young adults). Depending on the age group, internal exposure to phthalates and substitute Hexamoll® DINCH, brominated and organophosphorus flame retardants, per-/poly-fluorinated compounds, cadmium, bisphenols and/or polycyclic aromatic hydrocarbons are assessed. The main goal of the programme is to obtain quality controlled and comparable HBM data of exposure to chemicals, prioritized under HBM4EU, with European wide coverage to inform the development of environment and health policies. This paper describes the framework of the HBM4EU survey and the approach that has been applied to align European HBM initiatives across Europe.

Identifiers

Citations and references

Cited by 20 references